Ryan Zuzek is a Cardiology physician. OpenAlex indexes 9 publications with 291 citations (h-index 4).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
363 Vanadium Rd
Suite 300
Pittsburgh, PA 152431497
Telephone
412-429-8840Provider last certified this registry record 4 Mar 2021.
Industry payments
44 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Edwards Lifesciences CorporationProgram year202525 payments$13,693openpaymentsdata.cms.gov ↗
- Abbott LaboratoriesProgram year20259 payments
- HEARTFLOW, INC.Program year20254 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
79%Beta blocker23.3%Metoprolol Succinate46%Carvedilol26%Metoprolol Tartrate10%Sotalol9%Atenolol7%Sotalol Af1%Bisoprolol Fumarate1%Part D<11 patientsStatin13.9%Atorvastatin Calcium62%Rosuvastatin Calcium24%Simvastatin9%Pravastatin Sodium5%Part D≥202 patients+ 18 more classes in this area
Blood & clotting
17.9%Factor Xa inhibitor11.4%Eliquis82%Xarelto18%Part D≥155 patientsP2Y12 inhibitor5.6%Clopidogrel96%Brilinta4%Part D<11 patients+ 2 more classes in this area
Metabolism & gastrointestinal
2.4%Potassium supplement1.3%Potassium Chloride100%Part D≥30 patientsSGLT2 inhibitor1%Farxiga53%Jardiance48%Part D<11 patients+ 1 more class in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- ONE-YEAR OUTCOMES WITH OPTICAL COHERENCE TOMOGRAPHY GUIDANCE IN PERCUTANEOUS CORONARY INTERVENTION
Journal of the American College of Cardiology
2021 - Safety and efficacy of non-steroidal anti-inflammatory drugs to reduce ileus after colorectal surgery
British journal of surgery
2019 - An Angiographic and Intravascular Ultrasound Study of the Left Anterior Descending Coronary Artery in Takotsubo Cardiomyopathy
The American Journal of Cardiology
2011 - Influence of metabolic syndrome on outcome after percutaneous coronary intervention
Interventional Cardiology
2011 - Clinical Characteristics and Four-Year Outcomes of Patients in the Rhode Island Takotsubo Cardiomyopathy Registry
The American Journal of Cardiology
2009
Similar KOLs
Other experts from the same institution or the same specialty.
No other directory profiles share this institution yet.
Deepak Bhatt, MD
Icahn School of Medicine at Mount Sinai
Harlan Krumholz, MD
Yale School of Medicine
Scott Solomon, MD
Brigham and Women's Hospital
Eric Topol, MD
Scripps Research Institute (Scripps Research)
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”